{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-066013","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2023-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.987065+00:00","generated_at":"2026-06-14T11:34:57.740981+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Teladoc Health shareholders approve new incentive plan and ESPP amendment; severance plan for execs","bullets":["Shareholders approved the 2023 Incentive Award Plan, authorizing 8,250,000 shares for future equity grants.","ESPP amendment increases share reserve by 3,000,000 shares, removes evergreen clause, caps contributions at 15%.","Compensation Committee approved the Level 14 Severance Plan (effective June 1, 2023) for eligible executives.","Severance provides 6 months base salary (non-Change of Control) or 9 months plus 75% target bonus (Change of Control).","All nine director nominees elected; advisory vote on executive compensation passed (74.4M for vs 16.4M against)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-066013","json":"https://secwatch.observer/filing/0001104659-23-066013.json","markdown":"https://secwatch.observer/filing/0001104659-23-066013.md","text":"https://secwatch.observer/filing/0001104659-23-066013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000110465923066013/0001104659-23-066013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000110465923066013/tm2317113d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T11:34:57.740981+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0515347748c9f02cb031baa3857bf2a822e5f646","claim":"Teladoc Health, Inc. shareholders approved Approving an Amendment to the Teladoc Health, Inc. 2015 Employee Stock Purchase Plan.","evidence_excerpt":"Proposal 4 — Approving an Amendment to the Teladoc Health, Inc. 2015 Employee Stock Purchase Plan The stockholders of the Company approved an amendment to the Teladoc Health, Inc. 2015 Employee Stock Purchase Plan. The voting results are set forth below. For Against Abstentions Broker Non-Votes 90,596,731 615,655 117,620 28,923,619","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000110465923066013/0001104659-23-066013-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"227eee965848a1e53cd1928d236d39eee33f87e1","claim":"Teladoc Health, Inc. shareholders rejected Stockholder Proposal Entitled “Fair Elections”.","evidence_excerpt":"Proposal 6 — Voting on a Stockholder Proposal Entitled “Fair Elections” The stockholders of the Company did not approve a stockholder proposal entitled “Fair Elections”. The voting results are set forth below. For Against Abstentions Broker Non-Votes 14,994,415 75,977,425 358,166 28,923,619","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000110465923066013/0001104659-23-066013-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"failed"}],"fact_type":"shareholder_vote"},{"claim_id":"9542490ac61fe220dddae801558ce91279e34fda","claim":"Teladoc Health, Inc. shareholders approved Ratifying the Appointment of the Independent Registered Public Accounting Firm at the 2023-12-31 meeting.","evidence_excerpt":"Proposal 5 — Ratifying the Appointment of the Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The voting results are set forth below. For Against Abstentions Broker Non-Votes 118,869,979 757,876 625,770 N/A","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000110465923066013/0001104659-23-066013-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-31"}],"fact_type":"shareholder_vote"},{"claim_id":"b6a7d527b07eabff2c69e59e689021a9d6b8a291","claim":"Teladoc Health, Inc. shareholders approved Election of Directors.","evidence_excerpt":"Proposal 1 — Election of Directors The stockholders of the Company elected each of the following director nominees proposed by the Company’s Board of Directors to serve until the 2024 Annual Meeting of Stockholders of the Company and until their respective successors have been duly elected and qualified. The voting results for each director nominee are set forth below. Name For Against Abstentions Broker Non-Votes Karen L. Daniel 90,139,425 949,292 241,289 28,923,619 Sandra L. Fenwick 89,927,780 1,173,491 228,735 28,923,619 Jason Gorevic 90,172,443 924,178 233,385 28,923,619 Catherine A. Jacobson 90,113,407 975,068 241,531 28,923,619 Thomas G. McKinley 86,075,780 5,004,803 249,423 28,923,619 Kenneth H. Paulus 89,421,095 1,657,837 251,074 28,923,619 David L. Shedlarz 88,399,631 2,682,261 248,114 28,923,619 Mark Douglas Smith, M.D., MBA 89,898,033 1,180,486 251,487 28,923,619 David B. Snow, Jr. 86,958,904 4,162,296 208,806 28,923,619","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000110465923066013/0001104659-23-066013-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"c9a6fa226458795a7a6fdcece11cc78edf826b86","claim":"Teladoc Health, Inc. shareholders approved Approving the Teladoc Health, Inc. 2023 Incentive Award Plan.","evidence_excerpt":"Proposal 3 — Approving the Teladoc Health, Inc. 2023 Incentive Award Plan The stockholders of the Company approved the Teladoc Health, Inc. 2023 Incentive Award Plan. The voting results are set forth below. For Against Abstentions Broker Non-Votes 51,690,454 39,506,673 132,879 28,923,619","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000110465923066013/0001104659-23-066013-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"f9986d2952eee0361075694d465e0b29059d8c74","claim":"Teladoc Health, Inc. shareholders approved Advisory Vote Approving the Compensation of the Company’s Named Executive Officers.","evidence_excerpt":"Proposal 2 — Advisory Vote Approving the Compensation of the Company’s Named Executive Officers The stockholders of the Company approved, on an advisory basis, the compensation paid to the Company’s named executive officers. The voting results are set forth below. For Against Abstentions Broker Non-Votes 74,437,080 16,406,746 486,180 28,923,619","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000110465923066013/0001104659-23-066013-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}